These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 15270726)

  • 61. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
    Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
    J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
    Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
    J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
    [TBL] [Abstract][Full Text] [Related]  

  • 64. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
    al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
    Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
    Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
    Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses.
    Kim J; Choi SP; La S; Seo JS; Kim KK; Nam SH; Kwon B
    Exp Mol Med; 2003 Dec; 35(6):509-17. PubMed ID: 14749528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice.
    Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgström P; Lustgarten J
    Int J Cancer; 2005 Oct; 116(6):934-43. PubMed ID: 15856473
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The potential roles of 4-1BB costimulation in HIV type 1 infection.
    Wang S; Kim YJ; Bick C; Kim SH; Kwon BS
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):223-31. PubMed ID: 9491912
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combination therapy of established tumors by antibodies targeting immune activating and suppressing molecules.
    Takeda K; Kojima Y; Uno T; Hayakawa Y; Teng MW; Yoshizawa H; Yagita H; Gejyo F; Okumura K; Smyth MJ
    J Immunol; 2010 May; 184(10):5493-501. PubMed ID: 20400706
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
    Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA
    J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
    Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
    J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo.
    Weatherill AR; Maxwell JR; Takahashi C; Weinberg AD; Vella AT
    Cell Immunol; 2001 Apr; 209(1):63-75. PubMed ID: 11414737
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function.
    Lee SJ; Myers L; Muralimohan G; Dai J; Qiao Y; Li Z; Mittler RS; Vella AT
    J Immunol; 2004 Sep; 173(5):3002-12. PubMed ID: 15322159
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of 4-1BB molecule on peripheral blood T cells in liver transplanted patients and its clinical implication.
    Wan YL; Zheng SS; Jia CK; Liang TB; Huang DS; Wang WL; Li MW; Zhao ZC
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):38-43. PubMed ID: 14599927
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand.
    Gramaglia I; Cooper D; Miner KT; Kwon BS; Croft M
    Eur J Immunol; 2000 Feb; 30(2):392-402. PubMed ID: 10671194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection.
    Snell LM; McPherson AJ; Lin GH; Sakaguchi S; Pandolfi PP; Riccardi C; Watts TH
    J Immunol; 2010 Dec; 185(12):7223-34. PubMed ID: 21076066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapy.
    Wilcox RA; Flies DB; Wang H; Tamada K; Johnson AJ; Pease LR; Rodriguez M; Guo Y; Chen L
    Cancer Res; 2002 Aug; 62(15):4413-8. PubMed ID: 12154048
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal.
    Takahashi C; Mittler RS; Vella AT
    J Immunol; 1999 May; 162(9):5037-40. PubMed ID: 10227968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.
    Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB
    Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.